Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Franklin Genomic Advancements ETF Stock Price, Quotes and Forecasts
HELXBATS
Sector
Healthcare
Region
US
AUM
9.70M
Fund Score
Franklin Genomic Advancements ETF Price, Quotes and Forecasts | BATS:HELX | Benzinga
Explore Franklin Genomic Advancements ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HELX.
| Open | - |
| High | - |
| 52 Wk High | $33.98 |
| AUM | 9.70M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | - |
| Market Cap | $76.49B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 35.41 |
| Prev. Close | $29.27 |
| Low | - |
| 52 Wk Low | $28.30 |
| Shares Out | 300.00K |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 3.71K |
| Beta | 1.08 |
| Avg. Expense Ratio | 0.5% |
| P/B Ratio | 4.34 |
Recent News
Why Is Medpace Stock Diving On Tuesday?
Lekha Gupta
FAQ
Q
How do I buy Franklin Genomic Advancements ETF (HELX) stock?
A
You can purchase shares of Franklin Genomic Advancements ETF (BATS:HELX) through any online brokerage.
Q
Who are Franklin Genomic Advancements ETF (HELX) competitors?
A
There are no as such competitors for Franklin Genomic Advancements ETF.
Q
What is the forecast, or price target, for Franklin Genomic Advancements ETF (HELX) stock?
A
There is no analysis for Franklin Genomic Advancements ETF to provide a consensus price target.
Q
What is the current price for Franklin Genomic Advancements ETF (HELX)?
A
The stock price for Franklin Genomic Advancements ETF (BATS: HELX) is $29.2653 last updated February 28, 2025 at 8:00 PM EST.
Q
Does Franklin Genomic Advancements ETF (HELX) pay a dividend?
A
There are no upcoming dividends for Franklin Genomic Advancements ETF.
Q
When is Franklin Genomic Advancements ETF (BATS:HELX) reporting earnings?
A
Franklin Genomic Advancements ETF does not have any upcoming earnings scheduled.
Q
Is Franklin Genomic Advancements ETF (HELX) going to split?
A
There is no upcoming split for Franklin Genomic Advancements ETF.
| Open | - |
| High | - |
| 52 Wk High | $33.98 |
| AUM | 9.70M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | - |
| Market Cap | $76.49B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 35.41 |
| Prev. Close | $29.27 |
| Low | - |
| 52 Wk Low | $28.30 |
| Shares Out | 300.00K |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 3.71K |
| Beta | 1.08 |
| Avg. Expense Ratio | 0.5% |
| P/B Ratio | 4.34 |
About Franklin Templeton ETF Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Feb 25, 2020 |
| Managers | Matthew J. Moberg |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The Fund invests in equity securities inside and outside of the United States, including developing or emerging markets.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| MEDP | Medpace Holdings Inc | 6.31% |
| VRTX | Nvaesrtex Pharmaceutic... | 5.51% |
| REGN | Regeneron Pharmaceutic... | 5.18% |
| DHR | Danaher Corp. | 5.14% |
| TMO | Thermo Fisher Scientif... | 4.85% |
| KRYS | Krystal Biotech Inc | 4.80% |
| LLY | Eli Lilly & Co. | 4.17% |
| KR | Samsung Biologics Co L... | 3.30% |
| NTRA | Natera Inc | 3.04% |
| LN | Astrazeneca Plc, ADR | 2.60% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved